RRM1 and AL amyloidosis: Previous research has demonstrated that higher RRM1 expression is discovered to associated with shorter overall survival in non‐small cell lung cancer (NSCLC),24 non‐muscle‐invasive bladder cancer (NMIBC)25 and multiple myeloma patients.26